Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

Abroad (travel likely)Recruiting

Conditions

Invasive Breast Cancer Early Stages · Ductal Carcinoma In Situ, DCIS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NYU Grossman School of Medicine, New York, New York, United States
Contact: Study coordinator (Lucia Greco) · lucia.greco@nyulangone.org · 718-687-8702
Contact: Study coordinator (Nadia Chowdhury) · nadia.chowdhury@nyulangone.org · 347-327-4988
Contact: Principal Investigator (Naamit Gerber, MD)

Study leads

Naamit Gerber, MD
Principal Investigator
NYU Langone Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Breast Cancer · Ductal Carcinoma in Situ · Invasive Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer

Breast Cancer

Abroad (travel likely)Recruiting

Incheon, South Korea

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

Breast Cancer · Invasive Carcinoma of Breast · Ductal Breast Carcinoma in Situ

Abroad (travel likely)RecruitingPHASE2

Salt Lake City, United States

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Early-stage Breast Cancer · Hormone Receptor Positive Breast Carcinoma · Invasive Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Fullerton, United States · Los Alamitos, United States